9 Meters Biopharma, Inc. Appoints Samantha Ventimiglia to Board of Directors
RALEIGH, NC / ACCESSWIRE / October 4, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments...
News
Nutriband Inc.’s AVERSA(R) technology receives Notice of Allowance from United States Patent and Trademark Office (USPTO)
ORLANDO, FL / ACCESSWIRE / October 4, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical...
Turning Point Therapeutics Granted Breakthrough Therapy Designation for Repotrectinib Treatment in Patients with NTRK-Positive, TKI-Pretreated Advanced Solid Tumors
SAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation...
ContraFect’s New Phase 2 Exebacase Data Presented at IDWeekTM Demonstrates Rapid Symptom Resolution Among Patients with Staphylococcus aureus Bacteremia
YONKERS, New York, Oct. 04, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a late clinical-stage biotechnology company focused on the...
Revelation Biosciences Inc. Receives Approval to Begin a Phase 1b Clinical Study of REVTx-99 as an Experimental Treatment for Allergic Rhinitis and Chronic Nasal Congestion
-Phase 1b study will investigate the efficacy of REVTx-99 on nasal symptoms elicited by nasal allergen challenge- -Top-line data anticipated...
Love Pharma Makes Public Debut in Emerging Sexual Health, Wellness, and Psychedelics Markets
NEW YORK, NY, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Love Pharma Inc. (CSE: LUV), formerly Glenbriar Technologies, Inc., is a...
NeuroStar® Advanced Therapy Recognizes National Depression Education and Awareness Month With New Campaign Launch
Efforts feature mental health advocate and expert Dr. Melissa ShepardMALVERN, Pa., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:...
TriLink BioTechnologies® Extends EyeGene Partnership for COVID-19 Vaccine Development in South Korea
EyeGene expected to utilize TriLink’s CleanCap® technology and modified UTP manufactured by TriLink in the production of its EG-COVID mRNA...
Milestone Scientific Approved as Vendor to Supply CompuFlo® Epidural/ CathCheck™ Verification System Across Florida’s Memorial Heathcare System
ROSELAND, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments,...
PDS Biotech Enrolls First Stage of Checkpoint Inhibitor Naïve Patient Arm of Phase 2 Clinical Trial in Advanced HPV-16 Positive Head and Neck Cancer
FLORHAM PARK, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel...
Clinical Data Acquired by the PURE EP™ System Published in the Journal of Cardiac Electrophysiology
The PURE EP™ System is validated in multi-center study as superior to conventional sources of intracardiac signalsWestport, CT, Oct. 04,...
Maple Leaf Green World Inc. Announces Changes to its Board of Directors
CALGARY, Alberta, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“Maple Leaf” or the “Company”), (CSE: MGW)...
Quotient Limited Announces Appointment of New Chief Scientific & Medical Officer
JERSEY, Channel Islands, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment...
NextCure Announces New Appointments to its Board of Directors
BELTSVILLE, Md., Oct. 04, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and...
Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal Formulary
Largest Medicaid program in the U.S. adds Twirla to Preferred Drug List as of October 1, 2021PRINCETON, N.J., Oct. 04,...
Centessa Pharmaceuticals Announces $300 Million Financing Agreement with Oberland Capital
~ New $300 million facility, combined with Company’s cash balance as of June 30, 2021, provides access to over $900...
Brain Scientific and Piezo Motion Complete Merger and Announce Hassan Kotob as CEO of the Combined Company
The company also announced the closing of a $5 million financing round from U.S. institutions. Both parties to combine their...
Selecta Biosciences Announces Strategic Licensing Agreement with Takeda to Develop Next-Generation Gene Therapies for Patients with Lysosomal Storage Disorders
Selecta’s ImmTOR™ platform enhances transgene expression and addresses adeno-associated virus (AAV) vector immunogenicity constraints to deliver transformative therapiesWATERTOWN, Mass., Oct....
CytomX Therapeutics Appoints Dr. Alan Ashworth to Board of Directors
SOUTH SAN FRANCISCO, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company...
Parexel Strengthens Clinical Data and Digital Services Offering with Key Appointment
Former GSK Executive Stephen Pyke will lead and direct the operational execution and development of all facets of Parexel’s clinical...